Ani Pharmaceuticals, Inc.
Records under this name other than the patents Ani Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 6 of 6 · Back to Ani Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,696,906 | Stable Oral Suspensions of Baclofen Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,857,524 | Stable Oral Suspensions of Baclofen Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,858,662 | Medicament for the treatment of viral skin and tumour diseases Term ended Term ended Oct 2, 2026 · From the USPTO record | Term ended | Term ended Oct 2, 2026 | From the USPTO record |
| US 9,770,406 | Medicament for the treatment of viral skin and tumour diseases Term ended Term ended Jul 12, 2025 · From the USPTO record | Term ended | Term ended Jul 12, 2025 | From the USPTO record |
| US 10,434,059 | Medicament for the treatment of viral skin and tumour diseases Term ended Ended no later than Nov 18, 2022 · From the USPTO record | Term ended | Ended no later than Nov 18, 2022 | From the USPTO record |
| US 6,319,494 | Chimeric chains for receptor-associated signal transduction pathways Formerly held Term ended Term ended Nov 20, 2018 · From the USPTO record | Term ended | Term ended Nov 20, 2018 | From the USPTO record |